Literature DB >> 24881618

A new rosette in retinoblastoma.

Dipankar Das1, Kasturi Bhattacharjee, Sumita Sarma Barthakur, Prerana Sushil Tahiliani, Panna Deka, Harsha Bhattacharjee, Apurba Deka, Rajashree Paul.   

Abstract

Retinoblastoma, the most common primary malignant intraocular tumor of childhood is a great success story in pediatric and ocular oncology. Pathology of retinoblastoma is important to guide the treatment modalities. Differentiated retinoblastoma is commonly seen in younger age group. Since a hundred years, we have been observing two typical true rosettes in retinoblastoma in the form of Flexner-Wintersteiner (FW) and Homer Wright (HW) rosettes and in many occasions pseudorosettes have been documented. In the present case report, a third new type of rosette was identified in a differentiated retinoblastoma which had an unusual anterior segment involvement.

Entities:  

Mesh:

Year:  2014        PMID: 24881618      PMCID: PMC4065523          DOI: 10.4103/0301-4738.129786

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


Retinoblastoma is the most common primary intraocular malignancy in childhood, occurring in one in 14,000-20,000 live births.[12] This tumor is thought to have a neuroblastic origin from the nucleated layers of the retina.[2] Pathologically, retinoblastoma consists of cells with round, oval, or spindle-shaped nuclei that are approximately twice the size of lymphocytes.[23] Varying degrees of retinal differentiation evident as Homer Wright (HW) and Flexner-Wintersteiner (FW) rosettes and photoreceptor differentiation as in fleurettes occurs in the tumor.[23] Differentiated forms are more evident in younger age groups and as the age advances, the less well-differentiated variety becomes common.[12345] We present a unique new type of rosette that has never been reported earlier. This new type of rosette is characteristically different from the FW and HW rosettes, and was observed in a child of 2 months age with unilateral retinoblastoma.

Case Report

A 2-month-old female child, presented at a tertiary institute of northeast India with a white pupillary reflex in the left eye noticed by her parents. She was clinically diagnosed with retinoblastoma in the left eye and B-scan ultrasonography and computed tomography scan of the eye and orbit revealed an intraocular densely calcified soft tissue mass. Examination under general anesthesia prior to surgery confirmed the diagnosis of a unilateral intraocular retinoblastoma. Intraocular pressure was normal in both the eyes. Enucleation of the left eye with canthotomy and cantholysis to remove the enlarged globe was performed on the same day. The specimen was sent to the ocular pathology laboratory at the institute. After adequate fixation of the eyeball in 10% neutral buffered formalin, it was examined next day. The eyeball measured 20.84 mm anteroposteriorly, 19.6 mm horizontally, and 18.70 mm vertically. The cornea was 12.81 mm horizontally and 12.35 mm vertically; pupil was oval and measured 6.6 mm. Transected optic nerve measured 6.61 mm in length and 3.04 mm in diameter along with its meninges. There were no transillumination defects. The globe was sectioned vertically. A whitish, endophytic tumor occupying most of the vitreous cavity with specks of surface calcification was seen. Lateral calottes were cut separately and were submitted for histopathology. Separate transverse section of the distal end of optic nerve was cut and submitted for evaluation. Gross documentation was done [Fig. 1].
Figure 1

Gross documentation of retinoblastoma specimen. Surface calcification can be noted

Gross documentation of retinoblastoma specimen. Surface calcification can be noted Microscopic study of the specimen in hematoxylin and eosin (H and E) stain showed that basophilic tumor cells infiltrated part of the corneal endothelium [Fig. 2]. Foci of tumor cells were also seen in the anterior chamber [Fig. 2]. A large endophytic tumor arising from retinal layers with FW [Fig. 3] and HW [Fig. 4] rosettes were seen. The tumor was differentiated. Interestingly, a new variety of rosette was seen on light microscopy which was characteristically different from FW and HW rosettes. These newly observed rosettes had basophilic cuboidal cells inside the lumens of the rosettes [Fig. 5]. Like FW rosettes, the lumens were stained with alcian blue as it contained hyaluronidase-resistant acid mucopolysaccharides (HR-AMP) [Figs. 6–8]. The tumor showed foci of minimal necrosis, with one area of isolated calcification [Fig. 2]. Lateral calottes did not show choroidal involvement in the specimen and distal end of the cut end of optic nerve was free from tumor invasion. Patient was reviewed by an oncologist at a regional cancer center (RCC).
Figure 2

Basophilic tumor cells infiltrating anterior chamber and endothelium of cornea (hematoxylin and esoin (H and E, ×100)

Figure 3

Flexner-Wintersteiner (FW) rosette with clear lumen at the center (H and E, ×400)

Figure 4

Homer Wright (HW) rosette with central tangle of neural filament. There is no clear lumen at the center (H and E, ×400)

Figure 5

Newly observed rosette with basophilic cuboidal cells occupying the center of lumen. Cytoplasmic extensions of the cells can be noted. (H and E, × 400)

Figure 6

One of the newly observed rosettes stained with alcian blue (HR-AMP). Lumen was stained (×400). HR-AMP = hyaluronidaseresistant acid mucopolysaccharides

Figure 8

Necrosis and calcification (H and E, ×200)

Basophilic tumor cells infiltrating anterior chamber and endothelium of cornea (hematoxylin and esoin (H and E, ×100) Flexner-Wintersteiner (FW) rosette with clear lumen at the center (H and E, ×400) Homer Wright (HW) rosette with central tangle of neural filament. There is no clear lumen at the center (H and E, ×400) Newly observed rosette with basophilic cuboidal cells occupying the center of lumen. Cytoplasmic extensions of the cells can be noted. (H and E, × 400) One of the newly observed rosettes stained with alcian blue (HR-AMP). Lumen was stained (×400). HR-AMP = hyaluronidaseresistant acid mucopolysaccharides Alcian blue (HR-AMP) stained central lumen of FW rosette in same slide as control (×400) Necrosis and calcification (H and E, ×200)

Discussion

Rosettes are round assemblage of cells found in tumor.[234567] They usually consist of cells in a spoke circle, a halo collection surrounding a central or acellular lumen. Rosettes are so named for their similarity to the rose casement found in gothic cathedrals (beautiful rose porthole in the church of Notre-Dame in Strasbourg).[8] There are cluster of different kinds of rosettes in pathology, each with different kind of cells and dissimilar names.[28] Most of them are found in tumors of the nervous system.[289] The detection of rosettes help in the diagnosis of different tumors.[248] There are three types of true rosettes in pathology namely; 1. HW rosette, 2. FW rosette, and 3. true ependymal rosette.[478] Perivascular pseudorosette, which is often described in literature as a fourth type is not a true rosette.[8] First two rosettes and pseudorosettes are exclusively found in retinoblastoma.[258] HW rosette (named after James Homer Wright, the first director of the Massachusetts General Hospital, Boston, USA) is typically seen in neuroblastoma, medulloblastoma, primitive neuroectodermal tumors (PNETs) and retinoblastoma.[8] They lack a central lumen and their constituent cells encompass a central tangle of neural filaments. Their presence indicates neuroblastic differentiation.[289] FW rosette (named after pathologist Simon Flexner and ophthalmologist Hugo Wintersteiner) is feature of retinoblastoma.[8] It consists of tumor cells neighboring the central lumen, which is stained with alcian blue (HR-AMP) that contains cytoplasmic extensions from the tumor cells.[2589] FW rosettes represent early attempt at retinal differentiation and these rosettes are composed of a ring of cuboidal cells surrounding the central lumen. The lumen corresponds to subretinal space and stains with alcian blue (HR-AMP).[2589] The cells surrounding the lumen are joined near the apices by intracellular connections (zonulae adherents), which is analogous to the external limiting membrane of retina.[28910] FW rosettes are not pathognomonic because they also occur in malignant medulloepitheliomas and some pineal tumors.[249] On electron microscopy, they have features of primordial photoreceptor cells. Cilia, which exhibit the 9 + 0 pattern of microtubule doublets found in central nervous system's tumors, project in the lumen. Cilia are hypothesized to be the precursor of photoreceptor outer segments.[28910] Third rosette in pathology is a true ependymal rosette consisting of tumor cells surrounding an empty lumen. It is thought that these structures signify attempts by the tumor cells to remake ventricles with ependymal lining.[8] A pseudorosette consists of tumor cells collected around a viable blood vessel (perivascular pseudorosette).[8] It is called pseudorosette because the middle structure is not the part of the tumor. These types of rosettes are common in ependymomas, medulloblastoma, PNET, retinoblastoma, etc.[289] About 15-20% of retinoblastomas harbor very well-differentiated foci of actual photoreceptor differentiation. Such areas contain aggregates of neoplastic photoreceptors called fleurettes by T'so, Zimmerman, and Fine. Fleurettes are typically found in retinoblastomas on low magnification microscopy of H and E stained sections and are paucicellular compared to adjacent undifferentiated areas of viable tumors that appear relatively eosinophilic.[23910] Fleurettes denote bouquet-like, bulbous eosinophilic processes and are cytologically benign cells joined by series of zonulae adherents comprising a short segment of neoplastic external limiting membranes.[268] The newly observed rosettes in our retinoblastoma case, in addition to FW and HW rosettes consisted of clear lumens and inside the lumens there were collections of basophilic cells. By and large, this type of new rosette is larger than the FW or HW rosette. Peripheral outer cells were same as FW and HW rosettes. Like the FW rosette, the lumen was stained with alcian blue (HR-AMP). Eosinophilic cytoplasmic extensions were seen inside the lumen connecting the cells as well as outside peripheral cells as in FW rosette.[289] In our case, the anterior chamber involvement and minimal necrosis in differentiated retinoblastoma was somewhat unusual to explain. Normally, the mechanisms of tumor regression in retinocytoma are thought to be apoptosis and these regressions are caused by ischemic or immune-mediated necrosis. Our findings were incompatible with the histopathological features of retinocytoma.[2910]
  8 in total

1.  Malignant transformation of spontaneously regressed retinoblastoma, retinoma/retinocytoma variant.

Authors:  R C Eagle; J A Shields; L Donoso; R S Milner
Journal:  Ophthalmology       Date:  1989-09       Impact factor: 12.079

2.  The nature of retinoblastoma. I. Photoreceptor differentiation: a clinical and histopathologic study.

Authors:  M O Ts'o; L E Zimmerman; B S Fine
Journal:  Am J Ophthalmol       Date:  1970-03       Impact factor: 5.258

3.  Retinocytoma. A benign variant of retinoblastoma.

Authors:  C Margo; A Hidayat; J Kopelman; L E Zimmerman
Journal:  Arch Ophthalmol       Date:  1983-10

4.  The International Classification of Retinoblastoma predicts chemoreduction success.

Authors:  Carol L Shields; Arman Mashayekhi; Angela K Au; Craig Czyz; Ann Leahey; Anna T Meadows; Jerry A Shields
Journal:  Ophthalmology       Date:  2006-09-25       Impact factor: 12.079

5.  The relationship between tumor cell differentiation and age at diagnosis in retinoblastoma.

Authors:  Jagadeesan Madhavan; Anuradha Ganesh; Joseph Roy; Jyotirmay Biswas; Govindasamy Kumaramanickavel
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2008 Jan-Feb       Impact factor: 1.402

6.  High-risk features and tumor differentiation in retinoblastoma: a retrospective histopathologic study.

Authors:  Ralph C Eagle
Journal:  Arch Pathol Lab Med       Date:  2009-08       Impact factor: 5.534

7.  Retinoblastoma. Cell of origin.

Authors:  T M Nork; T L Schwartz; H M Doshi; L L Millecchia
Journal:  Arch Ophthalmol       Date:  1995-06

8.  Histopathologic analysis of 232 eyes with retinoblastoma conducted in an Indian tertiary-care ophthalmic center.

Authors:  Jyotirmay Biswas; Dipankar Das; S Krishnakumar; Mahesh P Shanmugam
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2003 Sep-Oct       Impact factor: 1.402

  8 in total
  5 in total

Review 1.  Diffuse anterior retinoblastoma: current concepts.

Authors:  Jing Yang; Yalong Dang; Yu Zhu; Chun Zhang
Journal:  Onco Targets Ther       Date:  2015-07-22       Impact factor: 4.147

2.  Molecular pathologic interpretation of new retinoblastoma rosettes.

Authors:  Dipankar Das; Panna Deka; Kasturi Bhattacharjee; Manab Jyoti Barman; Harsha Bhattacharjee; Divakant Misra; Rushil Kumar Saxena; Anusuya Bhattacharyya; Apurba Deka
Journal:  Indian J Ophthalmol       Date:  2017-08       Impact factor: 1.848

3.  L1 increases adhesion-mediated proliferation and chemoresistance of retinoblastoma.

Authors:  Dong Hyun Jo; Kyungmin Lee; Jin Hyoung Kim; Hyoung Oh Jun; Younghoon Kim; Young-Lai Cho; Young Suk Yu; Jeong-Ki Min; Jeong Hun Kim
Journal:  Oncotarget       Date:  2017-02-28

4.  Pathologic evidence of retinoblastoma seeds supported by field emission scanning electron microscopy and Raman spectroscopy.

Authors:  Dipankar Das; Kasturi Bhattacharjee; Manab J Barman; Harsha Bhattacharjee; Surjendu Maity; Dipankar Bandyopadhyay; Siddharth Thakur; Saurabh Deshmukh; Mohit Garg; Apurba Deka
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

5.  Immunohistochemistry on pattern of ocular & adnexal tumours in a tertiary eye care centre of Northeast India.

Authors:  Dipankar Das; Harsha Bhattacharjee; Apurba Deka; Panna Deka; Samir Serasiya; Kasturi Bhattacharjee; Jayanta Kumar Das; Ganesh Chandra Kuri; Eknath Pawar; Rushil Kumar Saxena
Journal:  Indian J Med Res       Date:  2018-01       Impact factor: 2.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.